Silverlake Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Silverlake Wealth Management's LLY Position: Q3 2026 in Review
Silverlake Wealth Management increased its Eli Lilly (LLY) stake by 0.61% in Q3 2026, buying an estimated $13K and bringing the position to 1,804 shares worth $2.09M. The position accounts for 0.39% of the portfolio, ranked #72.
Silverlake Wealth Management first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.19M in Q4 2025. 2,836 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Silverlake Wealth Management held 1,804 shares of Eli Lilly worth $2.09M as of Q3 2026.
- Silverlake Wealth Management bought 11 Eli Lilly shares in Q3 2026, an estimated $13K.
- Eli Lilly made up 0.39% of Silverlake Wealth Management's portfolio in Q3 2026, its #72 holding.
- Silverlake Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- Silverlake Wealth Management's Eli Lilly position peaked at $2.19M in Q4 2025.
- 2,836 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Silverlake Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.